The legacy of Sildenafil offers a complex case study for investors eyeing pharma. While early sales were explosive, present patent expiration and the rise of cheaper versions have considerably affected earnings. https://larazhaq690033.oblogation.com/39887505/viagra-and-big-pharma-a-precarious-stake